2
项与 Anti-HER2 CAR-T (Shenzhen Geno-Immune Medical ) 相关的临床试验Safety and Efficacy Evaluation of a Combination Immunotherapy Targeting Sarcomas
The aim of this clinical trial is to assess the feasibility, safety and efficacy of a combination low dose chemotherapy and immunotherapy in patients who have sarcoma that is relapsed or late staged. Another goal of the study is to assess the safety and efficacy of the therapy that combines multiple CAR T cells followed by sarcoma vaccines.
Multiple 4SCAR-T Cell Therapy Targeting Breast Cancer
The purpose of this study is to assess the feasibility, safety and efficacy of multiple 4th generation CAR-T cells targeting Her2, GD2, and CD44v6 surface antigen in breast cancer. Another goal of the study is to learn more about the activities of the multi-CAR T cells and their persistency in the patients.
100 项与 Anti-HER2 CAR-T (Shenzhen Geno-Immune Medical ) 相关的临床结果
100 项与 Anti-HER2 CAR-T (Shenzhen Geno-Immune Medical ) 相关的转化医学
100 项与 Anti-HER2 CAR-T (Shenzhen Geno-Immune Medical ) 相关的专利(医药)
100 项与 Anti-HER2 CAR-T (Shenzhen Geno-Immune Medical ) 相关的药物交易